Private AI vs API Wrappers — Why Infrastructure Ownership Matters
Most AI vendors resell OpenAI. We deploy models on your servers. Here's why that distinction matters for security, cost, and control.
Where Science Deciphers Life
We build genomics pipelines, clinical AI, and decision-support systems — turning biological data into care that's personal.
From raw sequencing data to personalized care — AI and bioinformatics for clinics, labs, and researchers.
Reproducible pipelines for WGS, WES, and targeted panels. Variant calling, annotation, and reporting — engineered for clinical labs and research.
Turn a person's genome into actionable recommendations. Nutrigenomics, pharmacogenomics, and risk-based interventions — for clinics and DTC products.
RAG systems built on PubMed, ClinVar, PharmGKB, and your guidelines. Clinicians get contextual answers cited to the source — never hallucinated.
Multilingual voice and chat agents that handle appointments, triage, FAQ, and follow-up — in Arabic and English, integrated with your stack.
AI for the research side: federated training across institutions, biomarker discovery, drug interaction prediction, and biomedical LLMs.
We combine deep technical expertise with a commitment to sovereignty and accountability.
Your models, your data, your servers. We build AI that runs entirely within your infrastructure — no external API calls, no data leakage.
We've shipped AI systems across finance, healthcare, and government. Not prototypes — production-grade deployments at scale.
One team handles architecture, development, deployment, and maintenance. No finger-pointing between vendors.
AI engineering meets bioinformatics. We speak both the language of transformers and the language of genomes.
From Sofia institutions to pan-European genomics initiatives — work and partnerships that shape what we build.
Bulgaria's oldest medical institution (1917). Partner for genomic and translational medicine projects.
VisitBulgarian center of excellence for molecular genetics, genomics, and personalized medicine, based at Medical University Sofia.
VisitEuropean biobanking research infrastructure across 23 countries — facilitating sample access and high-quality biomedical research.
VisitNational Bulgarian genome project — sequencing 6,500+ genomes across regions and ethnicities to build a population reference. Part of BBMRI.bg and a stepping stone to Genome of Europe.
VisitPan-European reference genome project — 100,000+ genomes representing Europe's diverse populations, backed by 49 partners across 27 countries.
VisitFederated EU genomic data infrastructure unlocking 1M+ genomes for research and personalized medicine. Co-funded by the Digital Europe Programme.
VisitAI-powered events and venues platform for Sofia. Bilingual (BG/EN) semantic search with vector embeddings and LLMs.
VisitMulti-tenant AI platform for Sofia projects — private K8s infrastructure powering vector search, RAG, and conversational agents.
VisitOMIXIS was born from a simple observation: organizations need AI systems they can actually own and control. Too many vendors, too little accountability, too much data leaving the building.
We started where the data is most sensitive — bioinformatics. Building genomic pipelines and AI systems for research institutions taught us that production-grade infrastructure and data sovereignty aren't optional.
Today we apply that same rigor to personalized medicine — building systems that turn genomes, clinical data, and scientific literature into care that's actionable, evidence-based, and personal.
To become a trusted technology partner for businesses and research institutions across MENA and Europe — building secure, scalable AI systems that enable innovation, discovery, and long-term growth.

Founder
Kamen is a bioinformatics engineer and AI infrastructure builder. He founded OMIXIS in 2025 to combine the work he does best: writing code, designing genomics pipelines, building MLOps systems, and training and fine-tuning AI models — engineered to actually run in production.
kamen.yovchev@omixis.comTechnical deep-dives on AI, bioinformatics, and modern infrastructure.
Most AI vendors resell OpenAI. We deploy models on your servers. Here's why that distinction matters for security, cost, and control.
How machine learning is transforming genomic data analysis, drug discovery, and biomarker identification in clinical research.
Retrieval-Augmented Generation connects AI to your internal documents. No hallucinations. No data leakage. Just answers.
Your model works in Jupyter. Now what? CI/CD for ML, model monitoring, drift detection, and reproducible deployments.
Forecasting demand, detecting anomalies, reducing churn. All running privately on your infrastructure.
Before writing a single line of code, you need to assess data maturity, team capacity, and infrastructure readiness.
Everything you need to know about our services and how we work.
Tell us about your project — we'll get back to you within 48 hours with a tailored proposal.
Or reach us directly: +359 878 28 68 36